MSAA Announces New Chairperson of Healthcare Advisory Council

The Multiple Sclerosis Association of America (MSAA) is proud to announce the new Chairperson of the Healthcare Advisory Council for the organization. Dr. Carrie Hersh, a multiple sclerosis specialist at the Cleveland Clinic Lou Ruvo Center for Brain Health – Las Vegas, has assumed the position. Dr. Hersh joined the faculty at the Cleveland Clinic […]

Read News Article

FDA Approves Generic Versions of Gilenya®

On December 5, 2019, the United States Food and Drug Administration (FDA) announced that they had approved the applications from three separate pharmaceutical companies for the first generic versions of Gilenya® (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.

Read News Article

What’s New in MS Research: November 2019

This edition of MSAA’s “What’s New in MS Research” provides highlights from this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. Experts from throughout the world gathered in Stockholm, Sweden in mid-September to share and discuss the latest research into the causes, diagnosis, course, and treatment of multiple sclerosis.

Read News Article

MSAA’s Magazine, The Motivator, Wins a 2019 National Health Information Award

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we have received an award from the 26th Annual National Health Information Awards! Each year, the National Health Information Awards honors high-quality consumer health information. MSAA received a Bronze Award for the Summer/Fall 2018 print edition of The Motivator in the National Health […]

Read News Article

Vumerity™ Oral Capsules Approved by the FDA for Adults with Relapsing Forms of MS, Including Active SPMS

On October 30, 2019, Biogen Inc. and Alkermes plc announced the United States Food and Drug Administration (FDA) approval of Vumerity (diroximel fumarate) oral capsules to treat adults with relapsing forms of multiple sclerosis (MS). This approval includes the treatment of clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS).

Read News Article

Multiple Sclerosis Association of America and Novartis Join Forces with TV Personality Montel Williams to Heighten Awareness of MS Progression through Storytelling

The Multiple Sclerosis Association of America (MSAA), in partnership with Novartis Pharmaceuticals Corporation and Emmy Award-winning television personality and multiple sclerosis (MS) advocate Montel Williams, announced today the launch of My MS Second Act. The educational program aims to improve awareness about MS disease progression and secondary-progressive MS (SPMS) and underscores the need for early […]

Read News Article

MSAA Partners with eSSENTIAL Accessibility

The Multiple Sclerosis Association of America (MSAA) is proud to announce a partnership with eSSENTIAL Accessibility, a comprehensive digital accessibility platform to assist in continuing MSAA’s commitment in providing informative and accessible resources to members of the multiple sclerosis (MS) community. Many individuals have difficulty typing, moving a mouse, or reading due to a variety […]

Read News Article

What’s New in MS Research: September 2019

If you have any doubts about the breadth and depth of ongoing research into the causes, nature, and treatment of multiple sclerosis (MS), the 12 items that follow should entirely allay those concerns. This latest edition of “What’s New in MS Research” reports on findings from the depths of the seas to the aisles of your local supermarket, and then to laboratories, hospitals, and MS clinics.

Read News Article

MSAA Announces New Chief Medical Officer

The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization. Barry A. Hendin, a highly accomplished neurologist who specializes in MS, has assumed the role. Preceding Dr. Hendin was Jack Burks, MD, a clinical professor of neurology for the Herbert Wertheim College of Medicine at […]

Read News Article